281 related articles for article (PubMed ID: 2170687)
1. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.
Gloss B; Bernard HU
J Virol; 1990 Nov; 64(11):5577-84. PubMed ID: 2170687
[TBL] [Abstract][Full Text] [Related]
2. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
3. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
4. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
6. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
8. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.
Demeret C; Yaniv M; Thierry F
J Virol; 1994 Nov; 68(11):7075-82. PubMed ID: 7933089
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
Chin MT; Broker TR; Chow LT
J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.
Oh ST; Kyo S; Laimins LA
J Virol; 2001 Jun; 75(12):5559-66. PubMed ID: 11356963
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel promoters in the genome of human papillomavirus type 18.
Karlen S; Beard P
J Virol; 1993 Jul; 67(7):4296-306. PubMed ID: 8389929
[TBL] [Abstract][Full Text] [Related]
13. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
Dong XP; Pfister H
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
[TBL] [Abstract][Full Text] [Related]
14. Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter.
Hasegawa T; Zhou X; Garrett LA; Ruteshouser EC; Maity SN; de Crombrugghe B
Nucleic Acids Res; 1996 Aug; 24(16):3253-60. PubMed ID: 8774909
[TBL] [Abstract][Full Text] [Related]
15. The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation.
Pereira DJ; Muzyczka N
J Virol; 1997 Jun; 71(6):4300-9. PubMed ID: 9151818
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
Steger G; Corbach S
J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
[TBL] [Abstract][Full Text] [Related]
17. A TATA-less promoter containing binding sites for ubiquitous transcription factors mediates cell type-specific regulation of the gene for transcription enhancer factor-1 (TEF-1).
Boam DS; Davidson I; Chambon P
J Biol Chem; 1995 Aug; 270(33):19487-94. PubMed ID: 7642633
[TBL] [Abstract][Full Text] [Related]
18. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.
Li R; Knight JD; Jackson SP; Tjian R; Botchan MR
Cell; 1991 May; 65(3):493-505. PubMed ID: 1850324
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.
May M; Grassmann K; Pfister H; Fuchs PG
J Virol; 1994 Jun; 68(6):3612-9. PubMed ID: 8189499
[TBL] [Abstract][Full Text] [Related]
20. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
